rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

James Richard Porter

President and CEO

Company insider

Files Form 4 as: President and CEO, Nuvalent.

Every Form 4 they filed

In numbers

Trades disclosed
180
Buys
0
Sells
21
Bought
$0
Sold
$66.1M
Companies
1
Companies where not an officer
0
First trade
4 Jan 2022
Last trade
15 Jul 2026
Last filed
15 Jul 2026

Companies traded

Where they are an officer
NuvalentDirector, Officer · Biotechnology · last 15 Jul 20260 buys · 21 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Jul 2026filed 15 Jul 2026NuvalentBiotechnologySEC FORM 4 Code U$25.2M203,529 at $124.00filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivative · BiotechnologySEC FORM 4 Code D—131,494filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivative · BiotechnologySEC FORM 4 Code D—161,100filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivative · BiotechnologySEC FORM 4 Code D—112,500filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivative · BiotechnologySEC FORM 4 Code D—46,250filing
15 Jul 2026filed 15 Jul 2026NuvalentBiotechnologySEC FORM 4 Code D—121,350filing
15 Jul 2026filed 15 Jul 2026NuvalentBiotechnologySEC FORM 4 Code A—40,025 at $0.00filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—508,942filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—49,401filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—33,423filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—867,172filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—118,686filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—131,494filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—161,100filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—112,500filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—46,250filing
15 Jul 2026filed 15 Jul 2026NuvalentBiotechnologySEC FORM 4 Code D—40,025filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivative · BiotechnologySEC FORM 4 Code D—508,942filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivative · BiotechnologySEC FORM 4 Code D—49,401filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivative · BiotechnologySEC FORM 4 Code D—33,423filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care7
Not placed21

Buys in green, sells in red, by the company’s sector.

Related people

James E. FlynnDirector and 10% owner and Other role · Director and 10% owner and Other at Nuvalent, filing Form 4 there in the last year
Ron SquarerDirector · Director at Nuvalent, filing Form 4 there in the last year
Sapna SrivastavaDirector · Director at Nuvalent, filing Form 4 there in the last year
Grant C. BogleDirector · Director at Nuvalent, filing Form 4 there in the last year
Michael L. MeyersDirector · Director at Nuvalent, filing Form 4 there in the last year